SUMMARY Indium-111 ("'In) bound to 8-hydroxyquinoline can be used to label platelets without impairing their ability to participate in active thrombosis. The purpose of this study was to identify intracardiac thrombi using "'In platelet scintigraphy. Twenty-nine patients were studied. Twenty-one had discrete left ventricular aneurysms (group 1). The remaining eight patients (group 2) had normal or minimally narrowed coronary vessels (< 50%) and a global ejection fraction of 54 ± 14% (mean i SD) without segmental dysfunction on contrast ventriculography. Six of the eight patients with insignificant coronary disease had severe mitral valve disease requiring surgery. Each intravenous injection contained 3.4 ± 1.6 X 109 platelets labeled in a solution of acid citrate dextrose and saline (1:7, pH 6.5) with 454 ± 144 ,Ci (mean ± SD) "'In complexed to 8-hydroxyquinoline with a final labeling efficiency of 67 ± 17%. Platelet recovery at 15 minutes was 37.8 + 14.5% (mean i SD; n = 15). Imaging was performed in the anterior, left anterior oblique 450 and left lateral views (the right anterior oblique 450 view was included in all except patients 1-5 in group 1) on the day of injection and at 1-2-day intervals for a maximum of 8 days. In group 1, nine patients had abnormal areas of increased activity within the left ventricle. Four required aneurysmectomy and had left ventricular thrombi; a fifth died and at autopsy evidence of a thrombus was found. In four patients (the only patients in whom these data were obtained), surface thrombus "'In activity was at least 9.7 times greater than that of blood, noninvolved myocardium and deeper aspects of the thrombus. Twelve patients with aneurysms had normal scintiphotos. Six required aneurysmectomy and were negative for thrombi. All the patients in group 2 had negative platelet scintiphotos. The six patients who required mitral valve replacement had no thrombi at surgery. Therefore, the diagnostic accuracy of platelet scintigraphy (both groups) in the 17 patients in whom surgical or postmortem confirmation of thrombi could be obtained, five of whom had positive scintiphotos, was 100%. We conclude from this preliminary study that "1'In platelet scintigraphy promises to be a reliable method for the identification of left ventricular thrombi.
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INDIUM-111 ("'In) is a gamma-emitting radionuclide that emits two photons per disintegration with energies of 173 and 247 KeV and has a half-life of 67 hours. It is well suited for scintigraphic imaging. When bound to 8-hydroxyquinoline, it forms a lipidsoluble compound that is an effective platelet label and does not appear to affect the ability of the cell to participate in thrombus formation.' Therefore, platelets labeled in this way seem suitable for the detection of hematologically active intracardiac thrombi.
Thirty to 70 percent5"8 of patients with left ventricular aneurysms, proved at autopsy or surgery, have mural thrombi. In clinical studies, systemic emboli occur in 6-13%5 9, 10 of patients with aneurysms, and the incidence is even higher in autopsy studies.8 11 Mural thrombi can only be definitively identified at autopsy or surgery. Diagnostic tests, including contrast ventriculography, cross-sectional echocardiography'2"14 and scanning with labeled fibrinogen'5' 18 and antibodies to fibrinogen,"7 have significant limitations.
Contrast ventriculography is invasive and not suitable for repeated studies when seeking information concerning the natural history, continuing activity and efficacy of therapy. In addition, it is not a validated standard against which other techniques can be measured, and lacks sensitivity. '8 20 Cross-sectional echocardiography is limited by the necessity for studies of particularly good quality to differentiate artifact from true lesions, and its value in the assessment of thrombus activity is uncertain. However, it provides spatial orientation not possible with M-mode studies and is noninvasive, and therefore, suitable for serial examinations. Fibrinogen labeled with 1251 and "''I and antibodies to fibrinogen have been used successfully to identify intracardiac thrombi. However, the physical properities of 1251 (not suitable for scintigraphic examination) and 131I (poor resolution) severely limit their clinical applicability. The use of antibodies to fibrinogen carries the risk of reaction to foreign protein, especially when given intravenously. In this report, we show that active left ventricular thrombi can be readily identified using "1In-labeled platelet scintigraphy, a technique that may not only define the location of the thrombus, but also reflect its activity.
Material and Methods

Patient Population
Twenty-nine patients were studied, 24 and saline (1:7). The pH was adjusted to 6.5-7.0 with 0.1 N NaOH solution in a tuberculin syringe with a 26-gauge needle. The oxine solution was prepared daily in 100% ethanol. Sterile suspensions of lllInlabeled platelets were prepared at room temperature under aseptic conditions in a laminar flow hood. Starting solutions were sterilized by millipore filtration. After the patients gave informed consent, whole blood was collected by venipuncture using a 19-gauge butterfly needle. Into a first syringe, 18 ml of blood were drawn into 2 ml of 38 g/l sodium citrate solution. Subsequent centrifugation at 2000 g for 10 minutes produced platelet-poor plasma, which was transferred into a plastic tube and saved. Into a second syringe, 43 ml of blood were drawn into 7 ml of modified ACD solution (Squibb). The blood was transferred to a sterile 50-ml conical plastic centrifuge tube and centrifuged at 200 g for 15 minutes. The upper threequarters of the platelet-rich plasma was transferred with sterile plastic disposable pipettes into 12-ml conical plastic tubes and centrifuged at 2000 g for 10 minutes.* The resultant platelet-poor plasma was saved and the cell button resuspended in ACD saline and centrifuged at 2000 g for 10 minutes.* The supernatant was decanted and the platelets were resuspended in the ACD saline solution containing the "'In-oxine complex and incubated at room temperature for 20 minutes. The labeled platelet suspension was centrifuged at 2000 g for 10 minutes* and the supernatant carefully decanted. The "'In activity remaining with the platelets was determined to estimate the in vitro labeling efficiency. The platelets were then resuspended in 4.0 ml of platelet-poor ACD plasma and incubated for 7 minutes to remove any non-cell-bound indium. The suspension was then centrifuged at 2000 g for 10 minutes* and the supernatant decanted. The platelet labeling efficiency was determined a second time. The platelet button was finally resuspended in 5-8 ml of platelet-poor citrated plasma. Phase contrast microscopy was used to detect gross platelet aggregates and contaminating leukocytes. Platelet aggregates were small and never exceeded five per high-power field. Contaminating leukocytes were sparse. The platelet suspension was injected intravenously using a 19-gauge butterfly needle. 
Calculation of Platelet Recovery
Platelet recovery was defined as the percentage of "'.In activity that remained with the platelets 15 minutes after the intravenous injection of the labeled platelets. It reflects the physiologic status of the platelet because abnormal or damaged platelets are sequestrated in the spleen, whereas physiologically normal platelets remain within the circulation. The platelet recovery was calculated as`3 CPM (1 ml WB*) X BV X 100 _ CPM (Std) X dilution factor CPM (I ml plasma*) X (l00-HCT) X BV CPM (Std) X dilution factor where WB = whole blood, HCT = hematocrit, CPM = counts per minute, Std = standard (0.1 ml of the platelet suspension in 1.9 ml of distilled water), dilution factor X Std = total amount of activity injected, and BV = blood volume (tables of Hurley24). All samples were prepared in duplicate and counted in batches using a NaT (TI) crystal well detector with the *Diluted to 2 ml with distilled water. Both aliquots were from the same sample.
spectrometer set to detect both peaks as well as the summation peak of "'In.
Results Cardiac Imaging (table 3) In all patients, well-defined images of the cardiac blood pool and great vessels were seen on day 1 The platelet preparation consisted of 3.4 1.6 X 10 (mean ± SD) platelets, with "'In activity of 454 ± 144 gCi (mean ± SD) and a final labeling efficiency of 67 ± 17%. Thrombus-positive patients were not statistically different from thrombus-negative patients with respect to injected "'In activity and the final labeling efficiency. However, more platelets were in-FIGURE 2. This scintiphoto was obtained 96 hours after injection of the platelet suspension. The orientation is similar to that infigure 1 LEFT LATERAL jected in the thrombus-negative patients (4.7 1.9 X 10O mean SD) than in the thrombus-positive patients (2.4 1.1 X l0) (p < 0.02).
The fate of the labeled platelets after injection of the suspension was determined in 15 patients. The percentage of labeled and injected platelets remaining in the circulation after 15 minutes was 37.8 ± 14.5% (mean + SD). This indicates that less than half of the platelets remained undamaged and within the circulation and thus were able to participate in any active thrombotic process that might be in progress. A comparison of the thrombus-positive and thrombusnegative patients showed no statistically significant difference between the two groups (39.7 ± 17.5% for thrombus-positive patients vs 36. 8 13.7% for thrombus-negative patients).
Discussion
The scintigraphic and surgical data provide convincing evidence that hematologically active intraventricular thrombi can be identified using "'In platelet scintigraphy. Scintigraphic findings were confirmed at surgery in the 11 figure 1 , the blood pool activity is significantly reduced. LAO -left anterior oblique.
tigraphic positive patients revealed high concentrations of "'In activity on the surface of the thrombus. This latter finding is further confirmation that the abnormal and increased cardiac activity identified by platelet scintigraphy was from the surface of thrombus, the most active portion of the clot. Normalized by mass, the "'In activity on the surface of the thrombus was 9.7-401.1 times greater than blood activity. In all patients, "'In activity below the surface of the clot was almost at background levels. The variation in surface activity may reflect differences in sample collection; some samples contained surface clot diluted with less active clot below the surface. Contrast ventriculography that showed a constant filling defect identified only 50% of the scintigraphically positive thrombi, and thus lacks the sensitivity of the newer technique. This finding is supported by data comparing ventriculography with surgery. In these studies, the sensitivity of ventriculography varied from 8-48%. 18 20 In two other patients, not operated upon and with negative scintiphotos, filling defects on the RAO contrast ventriculogram were seen. We assume that if these filling defects represent true lesions, they probably reflect inactive thrombi into which the labeled platelets were not incorporated. Because these patients were not operated upon, this suggestion remains speculative.
McAfee and Thakur2`2 6 were the first to label cells with indium. Subsequent studies in animals demonstrated the potential of indium-labeled platelets in the diagnosis of infective endocarditis,27 myocardial inTAiiit, 4 We had some problems with interpreting platelet images. In patients with elevated left hemidiaphragms, activity from the spleen may be confused with thrombi in the apex of the heart. The distinction is that splenic activity appears within minutes of injection, whereas thrombus activity is clearly visible only after 60 hours. It is also important to differentiate between increased blood pool activity due to increased blood volume and stasis in a large aneurysm from increased activity due to thrombus. Blood pool activity decreases with decay of the isotope and removal of platelets from the circulation whereas thrombus activity increases with time as more platelets accumulate at the site of thrombosis. Because emboli occur in 6-13% of patients with aneurysms, the relationship between the results of platelet scintigraphy and clinically important systemic emboli need to be studied in a larger series.
We conclude that the agreement between platelet scintigraphy and surgery in 17 operated patients, of which five were positive for thrombi, out of a total of 29, was 100%. Thus, this technique promises to be a sensitive and reliable method for the detection of hematologically active left ventricular thrombi.
THROMBI in coronary arteries of necropsy patients with transmural acute myocardial infarction (AMI) have been observed in numerous studies. Herrick, in 19121 and 1919,2 found them in four patients with fatal AMI, and for many decades thrombi were believed to have precipitated AMI. They were considered so important in causing this acute event that the term ''coronary thrombosis" was used for years to describe the event that most physicians now call "acute myocardial infarction."3 In recent years the primary role of coronary thrombus in precipitating AMI has been questioned. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] To evaluate the significance of coronary thrombus in AMI, we examined in detail the coronary arteries containing thrombi in 54 necropsy patients with transmural AMI. Several previously undescribed observations on coronary thrombi resulted, which clarify the significance of coronary thrombi in AMI.
Patients and Methods
All necropsy patients with transmural AMI accessioned in the Pathology Branch, National Heart, Lung, and Blood Institute, were reviewed. Of 235 such patients, 99 had histologic sections available from each 5-mm segment of each of the four major coronary arteries (right, left main, left anterior descending and left circumflex). Movat-stained histologic sections, approximately 55 per patient, were reviewed, and a thrombus was found in one of the four major coronary irteries in 54 patients (55%). These 54 patients constitute the study group.
In each patient, the coronary artery that contained the thrombus was examined. The maximal degree of
